CPT code 57421 represents a diagnostic pelvic examination of the vagina and cervix with an associated biopsy. The code captures procedures in which a clinician inspects the lower genital tract and obtains tissue from the vagina and/or cervix for histologic evaluation. Nationally, this code matters for coding consistency, quality measurement tied to gynecologic cancer detection pathways, and accurate capture of outpatient diagnostic services.

Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find information on typical sites of service, clinical context for use, and the operational implications of billing this procedure in outpatient and ambulatory surgical center settings. The publication also summarizes common modifier usage presented in payer materials and highlights benchmark considerations for reimbursement and claim adjudication.

The analysis provides clinicians, coding professionals, and policy staff with concise context on when 57421 is used, typical care settings, and payer coverage considerations. Data not available in the input are explicitly noted where applicable in the full publication.